Pharmaceutical plate is the most opportunity to undertake technology plate funds in the field, now technology plate is still very strong, as with the previous medical beauty of the big topic, but we have to clearly recognize a key point, that is, technology plate gone for a period of time, inside the many branches are pulled once again, similar to the previous medical beauty, and the medical beauty of the branch is also in the branch are pulled after the opening of the The funds outflow finishing, the funds outflow and will go to look for new hotspot opportunity board.
China Heng GroupChinese medicine manufacturing industry is the core leading industry of China Heng Group. After nearly fifty years of development, it is now a modernized comprehensive high-tech pharmaceutical enterprise, and has a pivotal position in the domestic traditional Chinese medicine manufacturing industry. Enterprise product resources, strong technical force, in the use of Chinese medicine theory research and development of Chinese medicine, cardio-cerebral vascular, gynecological field of medicine has a unique advantage.
Mastered a large number of independent intellectual property rights of the pharmaceutical technology and a set of mature products production process, especially in the Chinese medicine monomer active ingredients of the extraction technology results is in the domestic leading position. China Bone Pills and Gynecological Inflammatory Purity Capsules are two major products that have been awarded national invention patents, and several products such as Thrombolysis for Injection and Stone Tablets have been rated as high and new technology products.
Fosun PharmaFosun Pharma is a Shanghai-based private enterprise listed on the stock market in 1998. Founded by four Fudan graduates in 1992, Fosun Pharma is the predecessor of the Fosun Group and is now a part of the Fosun Group, with its business areas covering the pharmaceutical industry, pharmaceutical business, diagnostic reagents and medical devices. Its net profit and net assets rank third among China's listed pharmaceutical companies. At the same time, Fosun Pharma is also an excellent company specialized in investment, with good development prospects and quite strong corporate strength.
After the company's first biosimilar Rituxan is listed in 2019, the company is gradually stepping into the R&D harvesting period, and the approved biosimilars such as Rituximab and other innovative medicines,followed by Srolizumab, Bevacizumab and so on will be listed in succession, and the product structure will be optimized continuously,Innovative products will gradually become the main driving force of the company's performance growth,the company invested in the joint venture company Fosun Kite CAR-T products Akilunsai injection, CAR-T the first domestic listing, first-mover advantage is expected to hit the leading position.
KangdelaiZhejiang Kangdelai Medical Instrument Co., Ltd. was founded in 1987, the Kangdelai Group specializing in the production of medical puncture instrument series of manufacturers . The company integrates product research and development, production and sales, is one of the few domestic manufacturers with a complete industrial chain of medical puncture instruments, for the national high-tech enterprises, Zhejiang Provincial Enterprise Technology Center, won the Zhejiang Manufacturing Excellence, Zhejiang Provincial Export Brand, Zhejiang Province, Zhejiang Province, well-known trade names, Wenzhou City, the leading enterprises and other honorary titles. The company won the Wenzhou Mayor's Quality Award in 2019.
The company is mainly engaged in Engaged in the research, development, production and sales of medical devices, such as medical puncture needles, medical infusion devices, interventional devices and other medical devices, which are widely used in clinical applications. Based on a strong R & D platform, the company and a number of well-known domestic institutions of higher learning, scientific research units to carry out in-depth cooperation, the formation of the integration of production, learning, research, and currently has 47 patents of various types. All kinds of automated product production line, intelligent sterilization system to, intelligent three-dimensional library and "intelligent manufacturing" and other projects, become the industry "machine for man", "fusion of two" demonstration benchmark enterprises The company has been a model benchmark enterprise in the industry of "machine for man" and "integration of the two".
Taiji GroupTaiji Group is a wholly state-owned enterprise 100% owned by Chongqing Fuling District State-owned Assets Supervision and Administration Commission (SASAC), and belongs to the local state-owned enterprises in Chongqing Fuling District. The "Taiji Group" in the listed company refers to Taiji Industrial Group Co. Taiji Industrial Group is a subsidiary of Taiji Group, and the ultimate controlling interest belongs to the State-owned Assets Supervision and Administration Commission of Fuling District, so it is also a local state-owned enterprise in Fuling District. But Taiji Industrial Group has shareholders of a non-state nature, so it is not a wholly state-owned enterprise, but a state-owned joint-stock enterprise with state-owned capital.
China Electronics Corporation (CEC) is an important state-owned enterprise approved by the State Council and established on the basis of electronic research institutes and high-tech enterprises directly under the former Ministry of Information Industry (MII), and is a vice-ministerial-level military group under the direct management of the central government. Mainly engaged in the national important military and civilian large-scale electronic information system engineering construction, major equipment, communications and electronic equipment, software and key components of the development and production.